Trials / Completed
CompletedNCT01638182
Biocomparison Study
Comparison of Effects of Nutritional Doses Vitamin K1 and K2 on Carboxylation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The effects of two vitamin K-forms on carboxylation of the vitamin K-dependent proteins osteocalcin and matrix-gla protein will be compared after supplementing these vitamins in a nutritional dose range. The investigators hypothesized that MK-7 is more effective than K1 at a dose comparable to the RDA of vitamin K.
Detailed description
Vitamin K is a group name for the naturally occurring phylloquinone (K1) and menaquinones (MK-n; K2). The latter can be subdivided into the short-chain (e.g. MK-4) and the long-chain (e.g. MK-7, MK-8, and MK-9) menaquinones. Earlier studies have shown that high vitamin K intake leads to improved bone and vascular health by increased carboxylation of vitamin K-dependent proteins in these tissues. In the dietary range, MK-7 has been suggested to be the most effective cofactor for the carboxylation of Gla-proteins, such as osteocalcin (OC) and matrix-Gla protein (MGP).Until now, no randomized controlled trial has compared the efficacy of K1 versus MK-7 in a nutritional dose range. The investigators are therefore interested to compare the effects of K1 and MK-7 on OC and MGP carboxylation after supplementing these vitamins at a dose not exceeding the RDA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | 27 participants received for three months 1 placebo capsule per day |
| DIETARY_SUPPLEMENT | Vitamin K1-capsules | 27 participants received for 3 months 1 vitamin K1-capsule per day containing 52 µg of K1/day |
| DIETARY_SUPPLEMENT | Vitamin K2-capsules | 27 participants received for 3 months 1 vitamin K2-capsule per day containing 75 µg of MK-7. |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-06-01
- Completion
- 2011-09-01
- First posted
- 2012-07-11
- Last updated
- 2012-07-11
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01638182. Inclusion in this directory is not an endorsement.